The effect of enalapril and carvedilol on left ventricular dysfunction in middle childhood and adolescent patients with muscular dystrophy

Korean Circulation Journal

Volumn 42, Issue 3, 2012, Pages 184-191

  Kwon, Hye Won ^a   Kwon, Bo Sang ^a   Kim, Gi Beom ^a   Chae, Jong Hee ^a   Park, June Dong ^a   Bae, Eun Jung ^a   Noh, Chung Il ^a  

^a Seoul National University Children's Hospital   (South Korea)

Author keywords

Cardiomyopathies; Carvedilol; Echocardiography; Enalapril; Muscular dystrophies

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; CARVEDILOL; ENALAPRIL;

ABSENCE OF SIDE EFFECTS; ADOLESCENT; ADOLESCENT DISEASE; ARTICLE; BECKER MUSCULAR DYSTROPHY; BRADYCARDIA; CHILD; CHILDHOOD DISEASE; CLINICAL ARTICLE; COUGHING; DIZZINESS; DRUG EFFICACY; DUCHENNE MUSCULAR DYSTROPHY; ECHOCARDIOGRAPHY; HEART LEFT VENTRICLE ENDSYSTOLIC VOLUME; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE FUNCTION; HUMAN; HYPOTENSION; MALE; PROSPECTIVE STUDY; SCHOOL CHILD; VOLUMETRY;

EID: 84859921451     PISSN: 17385520     EISSN: 17385555     Source Type: Journal    
DOI: 10.4070/kcj.2012.42.3.184     Document Type: Article

References (31)

1. Emery AE. The muscular dystrophies. Lancet 2002;359:687-95. (Pubitemid 34203773)
2. Emery AE. Population frequencies of inherited neuromuscular diseases: world survey. Neuromuscul Disord 1991;1:19-29.
3. Finsterer J, Stöllberger C. The heart in human dystrophinopathies. Cardiology 2003;99:1-19. (Pubitemid 36206630)
4. McNally EM. Duchenne muscular dystrophy: how bad is the heart? Heart 2008;94:976-7. (Pubitemid 352039876)
5. Kaspar RW, Allen HD, Montanaro F. Current understanding and management of dilated cardiomyopathy in Duchenne and Becker muscular dystrophy. J Am Acad Nurse Pract 2009;21:241-9.
6. Jefferies JL, Eidem BW, Belmont JW, et al. Genetic predictors and remodeling of dilated cardiomyopathy in muscular dystrophy. Circulation 2005;112:2799-804. (Pubitemid 41641674)
7. Duboc D, Meune C, Lerebours G, Devaux JY, Vaksmann G, Bécane HM. Effect of perindopril on the onset and progression of left ventricular dysfunction in Duchenne muscular dystrophy. J Am Coll Cardiol 2005;45:855-7. (Pubitemid 40342808)
8. Duboc D, Meune C, Pierre B, et al. Perindopril preventive treatment on mortality in Duchenne muscular dystrophy: 10 years' follow-up. Am Heart J 2007;154:596-602. (Pubitemid 47268252)
9. Giglio V. Left ventricular function and response to enalapril in patients with Duchenne muscular dystrophy during the second decade of life. Am J Cardiol 2007;99:147-8. (Pubitemid 44969359)
10. Saito T, Matsumura T, Miyai I, Nozaki S, Shinno S. Carvedilol effectiveness for left ventricular-insufficient patients with Duchenne muscular dystrophy. Rinsho Shinkeigaku 2001;41:691-4. (Pubitemid 34601526)
11. Reisner SA, Lysyansky P, Agmon Y, Mutlak D, Lessick J, Friedman Z. Global longitudinal strain: a novel index of left ventricular systolic function. J Am Soc Echocardiogr 2004;17:630-3. (Pubitemid 38858038)
12. Sahn DJ, DeMaria A, Kisslo J, Weyman A. Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation 1978;58:1072-83. (Pubitemid 9091990)
13. Garcia MJ, Thomas JD, Klein AL. New Doppler echocardiographic applications for the study of diastolic function. J Am Coll Cardiol 1998;32:865-75. (Pubitemid 28459571)
14. Tei C, Ling LH, Hodge DO, et al. New index of combined systolic and diastolic myocardial performance: a simple and reproducible measure of cardiac function: a study in normals and dilated cardiomyopathy. J Cardiol 1995;26:357-66. (Pubitemid 26011184)
15. Sohn DW, Chai IH, Lee DJ, et al. Assessment of mitral annulus velocity by Doppler tissue imaging in the evaluation of left ventricular diastolic function. J Am Coll Cardiol 1997;30:474-80.
16. Devereux RB, Reichek N. Echocardiographic determination of left ventricular mass in man: anatomic validation of method. Circulation 1977;55:613-8. (Pubitemid 8066109)
17. Lamparter S, Sun Y, Weber KT. Angiotensin II receptor blockade during gestation attenuates collagen formation in the developing rat heart. Cardiovasc Res 1999;43:165-72. (Pubitemid 29322876)
18. Bernai J, Pitta SR, Thatai D. Role of the renin-angiotensin-aldosterone system in diastolic heart failure: potential for pharmacologic intervention. Am J Cardiovasc Drugs 2006;6:373-81. (Pubitemid 46072393)
19. Ramaciotti C, Heistein LC, Coursey M, et al. Left ventricular function and response to enalapril in patients with Duchenne muscular dystrophy during the second decade of life. Am J Cardiol 2006;98:825-7. (Pubitemid 44301021)
20. Francis GS, Benedict C, Johnstone DE, et al. Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure: a substudy of the Studies of Left Ventricular Dysfunction (SOLVD). Circulation 1990;82:1724-9. (Pubitemid 20367975)
21. Cha DH, Cha YS, Kook JH, et al. Clinical efficacy of carvedilol in patients with moderate to severe congestive heart failure. Korean Circ J 1998;28:523-31.
22. Bruns LA, Chrisant MK, Lamour JM, et al. Carvedilol as therapy in pediatric heart failure: an initial multicenter experience. J Pediatr 2001;138:505-11. (Pubitemid 32319723)
23. Ishikawa Y, Bach JR, Minami R. Cardioprotection for Duchenne's muscular dystrophy. Am Heart J 1999;137:895-902. (Pubitemid 29226300)
24. Kajimoto H, Ishigaki K, Okumura K, et al. Beta-blocker therapy for cardiac dysfunction in patients with muscular dystrophy. Circ J 2006;70:991-4. (Pubitemid 44161734)
25. Ogata H, Ishikawa Y, Ishikawa Y, Minami R. Beneficial effects of beta-blockers and angiotensin-converting enzyme inhibitors in Duchenne muscular dystrophy. J Cardiol 2009;53:72-8.
26. American Academy of Pediatrics Section on Cardiology and Cardiac Surgery. Cardiovascular health supervision for individuals affected by Duchenne or Becker muscular dystrophy. Pediatries 2005;116:1569-73.
27. Bahler RC, Mohyuddin T, Finkelhor RS, Jacobs IB. Contribution of Doppler tissue imaging and myocardial performance index to assessment of left ventricular function in patients with Duchenne's muscular dystrophy. J Am Soc Echocardiogr 2005;18:666-73. (Pubitemid 40798455)
28. Giatrakos N, Kinali M, Stephens D, Dawson D, Muntoni F, Nihoyannopoulos P. Cardiac tissue velocities and strain rate in the early detection of myocardial dysfunction of asymptomatic boys with Duchenne's muscular dystrophy: relationship to clinical outcome. Heart 2006;92:840-2. (Pubitemid 43799230)
29. Ogata H, Nakatani S, Ishikawa Y, et al. Myocardial strain changes in Duchenne muscular dystrophy without overt cardiomyopathy. Int J Cardiol 2007;115:190-5. (Pubitemid 46138125)
30. Tsutamoto T, Wada A, Maeda K, et al. Attenuation of compensation of endogenous cardiac natriuretic peptide system in chronic heart failure: prognostic role of plasma brain natriuretic peptide concentration in patients with chronic symptomatic left ventricular dysfunction. Circulation 1997;96:509-16. (Pubitemid 27329427)
31. Mori K, Manabe T, Nii M, Hayabuchi Y, Kuroda Y, Tatara K. Plasma levels of natriuretic peptide and echocardiographic parameters in patients with Duchenne's progressive muscular dystrophy. Pediatr Cardiol 2002;23:160-6. (Pubitemid 36927893)